Who owns Stoke Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of STOK from SEC Form 13F filings across 197 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 197 institutions disclosed 76.2M shares of Stoke Therapeutics, Inc. worth $2.49B — about 115.5% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
197
13F holders
$2.49B
value, 2026 filers
115.5%
of shares outstanding (76.2M sh)
32
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of STOK's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 5.9M | $192.3M | 0.0% | 8.9% | +9.1% |
| 2 | RTW INVESTMENTS, LP | 5.6M | $184.0M | 1.6% | 8.5% | 0.0% |
| 3 | FMR LLC | 5.3M | $173.8M | 0.0% | 8% | -1.3% |
| 4 | Lynx1 Capital Management LP | 4.0M | $132.1M | 15.3% | 6.1% | -15.2% |
| 5 | Redmile Group, LLC | 3.9M | $129.1M | 8.7% | 6% | -5.2% |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | 3.5M | $115.2M | 0.0% | 5.3% | +13.7% |
| 7 | MORGAN STANLEY | 3.5M | $113.0M | 0.0% | 5.2% | +0.9% |
| 8 | BAKER BROS. ADVISORS LP | 3.3M | $109.2M | 0.5% | 5.1% | 0.0% |
| 9 | TORONTO DOMINION BANK | 3.2M | $103.8M | 0.1% | 4.8% | 0.0% |
| 10 | STATE STREET CORP | 2.9M | $93.3M | 0.0% | 4.3% | +25.3% |
| 11 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.7M | $87.1M | 0.0% | 4% | +37.6% |
| 12 | VANGUARD CAPITAL MANAGEMENT LLC | 2.6M | $84.6M | 0.0% | 3.9% | +9.8% |
| 13 | BVF INC/IL | 2.5M | $83.4M | 2.1% | 3.9% | 0.0% |
| 14 | T. Rowe Price Investment Management, Inc. | 2.4M | $79.0M | 0.1% | 3.7% | +862.5% |
| 15 | Siren, L.L.C. | 2.0M | $65.3M | 1.3% | 3% | 0.0% |
| 16 | DEERFIELD MANAGEMENT COMPANY, L.P. | 1.8M | $59.7M | 0.6% | 2.8% | 0.0% |
| 17 | Jupiter Topco LLCNEW | 1.8M | $59.4M | 0.0% | 2.7% | new |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 1.5M | $49.9M | 0.0% | 2.3% | +15.3% |
| 19 | Assenagon Asset Management S.A. | 1.1M | $36.9M | 0.0% | 1.7% | +24.4% |
| 20 | DIMENSIONAL FUND ADVISORS LP | 1.0M | $33.2M | 0.0% | 1.5% | +2.4% |
| 21 | Polar Capital Holdings Plc | 833,716 | $27.3M | 0.1% | 1.3% | -26.4% |
| 22 | EcoR1 Capital, LLC | 735,000 | $24.0M | 1.2% | 1.1% | +635.0% |
| 23 | MPM BIOIMPACT LLC | 723,314 | $23.7M | 1.4% | 1.1% | -5.7% |
| 24 | Opaleye Management Inc. | 700,000 | $22.9M | 2.1% | 1.1% | 0.0% |
| 25 | GOLDMAN SACHS GROUP INC | 575,344 | $18.8M | 0.0% | 0.9% | -30.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.